News and Publications

Find out about the latest news, announcements, and research from IMIDomics.

scroll down
latest news
In the News
Dec 7, 2022

IMIDomics Announces Appointment of Key Science and Medical Research Experts to Newly Formed Immunology Advisory Board
In the News
Mar 23, 2022

CataloniaBio & HealthTech has awarded IMIDomics with the Bioèxit Award | Award acceptance speech by co-founder and CMO, Dr. Sara Marsal
In the News
Feb 15, 2022

IMIDomics, Inc. Announces Strategic Investment from Drug Discovery and Research Leader Evotec SE
In the News
Dec 7, 2021

IMIDomics™ Announces Scientific and Business Advisory Boards
In the News
Oct 7, 2021

IMIDomics sponsors the online Symposium “Combination therapies in common diseases: clinical and translational challenges”, October 7th 2021
In the News
Jul 27, 2021

IMIDomics™ Closes $16.5 Million Series A Financing to Advance its Precision Discovery Platform for Immune-Mediated Inflammatory Diseases
In the News
Jul 20, 2021

IMIDomics co-organizes symposium "Combination therapies in common diseases: clinical and translational challenges"
In the News
Oct 16, 2020

Drug candidate for severe COVID-19 identified by IMIDomics and VHIR Rheumatology Group selected for NIH clinical trial
In the News
May 20, 2020

IMIDomics funds a study that identifies a new drug candidate to prevent severe COVID-19
In the News
Feb 2, 2020

IMIDomics and Gossamer Bio Enter into a Strategic Collaboration to Advance the Development of Novel Treatments for Patients with Immune-Mediated Inflammatory Diseases
In the News
Dec 1, 2019

IMIDomics granted Horizon 2020 project on Systems approaches for the discovery of combinatorial therapies for complex disorders

Get in touch for further information

- please enter your name
- please enter a valid email
Let’s partner to improve lives
Thank you!
Your message has been received!
Oops! Something went wrong while submitting the form.